Tag:
Exubera
Latest Headlines
Latest Headlines
Partnership brings inhaled insulin closer to reality
A Holy Grail in the drug-delivery business is the quest for a needle-free way for diabetics to take their insulin. Galway, Ireland-based Aerogen and San Francisco-based Dance Pharmaceuticals believe
Partnership brings inhaled insulin closer to reality
A Holy Grail in the drug-delivery business is the quest for a needle-free way for diabetics to take their insulin. Galway, Ireland-based Aerogen and San Francisco-based Dance Pharmaceuticals believe
MannKind defies analysts skeptical of inhaled insulin drug
Several analysts have made sport of MannKind's quest to obtain FDA approval of an inhaled insulin drug. If Pfizer couldn't do it with Exubera, they reason, how can MannKind find success? And that has
Pfizer hangs sale sign on Exubera plant
Call your Realtor: Pfizer has put its ex-Exubera plant up for sale. The Terre Haute, Indiana, facility had been in the Pfizer family since 1948, when the drugmaker bought it from the U.S. government.
SPOTLIGHT: Ex-Exubera plant to shut down
Pfizer will shutter its sterile manufacturing plant in Terre Haute--where the now-defunct inhaled insulin product Exubera was made--by mid-2009, eliminating the facility's remaining 140 jobs. More
What Exubera says about safety
When Pfizer announced yesterday that the inhaled insulin product it spiked last fall may have triggered lung cancer in a few patients, pundits immediately pronounced the death of all insulin
ALSO NOTED: Crucell shares up on TB data; Celera, Merck ink cancer deal; and much more...
> A federal patent office may appeal a court ruling that threw out a new cap limiting the number of times a company can resubmit patent applications. That change was aggressively contested by the
Inhaled insulin lung cancer warning riles investors
The inhaled insulin field got blitzed again today after Nektar Therapeutics  and Pfizer reported an increased number of
Pfizer focuses on expanding inhaled meds R&D
Pfizer is budgeting €130 million for the construction of a new facility in France to specialize in the development of inhaled meds. Plans for the facility in Amboise include a staff of 440,
Pfizer cuts 660 at Exubera plant
Workers at Pfizer's Terre Haute, Indiana, plant where the ill-fated Exubera was made are, shall we say, less than exuberant today. The company has decided to cut 660 jobs there; after all, it's not
